Home Stanotrex®150

StanoTrex®150 10ml vial

Stanozolol Injection 150mg/ml, 10 mL Multidose Vial



Therapeutic Class:
Anabolic Agent


Each 1 ml of STANOTREX150 contains

150 mg Stanozolol

Sterile Water Solution

For Intramuscular Administration

Indication & Dosage:

Stanozolol is used in the treatment of hereditary angioedema,
which causes episodes of swelling of the face, extremities,
genitals, bowel wall, and throat. Stanozolol may decrease the
frequency and severity of these attacks.


Vascular manifestations of Behcet’s syndrome

Adult: 10 mg daily.


Hereditary angioedema

Adult: Initially, 2.5-10 mg daily, reduced according to response.
Maintenance: 2 mg daily or on alternate days or 2.5 mg 3 times wkly.

Child: <6 yr: 1 mg daily; 6-12 yr: Up to 2 mg daily.



Adult: 50 mg every 2-3 wk.



Adult: 50 mg every 2-3 wk.


Breast cancer in postmenopausal women

Adult: 50 mg every 2-3 wk.


Catabolic disorders

Adult: 50 mg every 2-3 wk..


Heart or blood vessel disease; had a heart attack;

a high level of cholesterol in the blood; bleeding or blood clotting problems;

diabetes; using oral anticoagulant (blood thinner); liver problems; or kidney problems
Pregnancy and lactation; carcinoma of prostate or breast in men, hypercalcaemia, hypercalciuria, porphyria, severe hepatic impairment.
    Special Precautions          
Patients with cardiac, renal or hepatic disease, epilepsy or DM. Children, elderly.

Monitor liver function, haematocrit and haemoglobin concentrations. Not

recommended for treatment of hereditary angioedema in premenopausal women.
    Adverse Drug Reactions   
In rare cases, serious and even fatal cases of liver problems have developed

during treatment with stanozolol. Contact your doctor immediately if you experience

abdominal pain, light colored stools, dark colored urine, unusual fatigue, nausea or

vomiting, or yellowing of the skin or eyes. These may be early signs of liver problems.

If you experience any of the following serious side effects, contact your doctor

immediately or seek emergency medical attention:an allergic reaction (difficulty breathing;

closing of the throat; swelling of the lips, tongue, or face; or hives);

swelling of the arms or legs (especially ankles); frequent or persistent erections, or

breast tenderness or enlargement (male patients); orvoice changes (hoarseness,

deepening), hair loss, facial hair growth, clitoral

enlargement, or menstrual irregularities (female patients).

Other less serious side effects may also occur. Talk to your doctor if you experience

new or worsening acne;difficulty sleeping;headache; orchanges in sexual desire.

Side effects other than those listed here may also occur. Talk to your doctor about

 any side effect that seems unusual or that is especially bothersome.

   Drug Interactions                
Enhances activity of insulin, sulfonylureas, levothyroxine and anticoagulants e.g.

warfarin. May cause resistance to the effects of neuromuscular blockers.

Potentially Fatal: Enhances activity of insulin, sulfonylureas, levothyroxine and

anticoagulants e.g. warfarin. May cause resistance to the effects of neuromuscular blockers.

 Pregnancy Category
Category X: Studies in animals or human beings have demonstrated foetal

abnormalities or there is evidence of foetal risk based on human experience

or both, and the risk of the use of the drug in pregnant women clearly

outweighs any possible benefit. The drug is contraindicated in women who are or may become pregnant.

    Mechanism of Action         
Stanozolol is a structural analogue of testosterone which increases collagen

production and decreases the anti-anabolic action of cortisone. It is also reported

to reduce fibrin deposition. It corrects the formation of kinin or kinin-like factors

which may be associated with oedema and swelling seen in hereditary angioedema.

Metabolism: Hepatic.

Excretion: Urine (90%), faeces (6%).


Store at room temperature, between 59 and 86 degrees F (15 and 30 degrees C), in a tightly-closed container. Store away from heat, moisture, and light.

Do not store in the bathroom. Keep out of the reach of children and away from pets.

Concentrex Laboratiories N. V., Moerstraat 58, 9031, Gent, Belgium

Reg. No. Licence: 253/55-C9/2010/BE
Manufactured under WHO cGMP guidelines
Date of Preparation : 19 july 2010